MedPath

The Addition of Whole Grains to the Diets of Adults: A Study of Digestive Health and Natural Defenses

Not Applicable
Completed
Conditions
Digestive Health and Immune Function
Interventions
Other: Whole grains
Other: Refined grains
Registration Number
NCT01902394
Lead Sponsor
Tufts University
Brief Summary

The purpose of this study is to determine if substituting whole grains for refined grains in the diets of healthy adults over a period of 6 weeks alters the composition of the bacteria in the gut, and has beneficial effects on immune function, digestive health, cardiovascular health, regulation of body weight and composition, and vitamin K status.

The investigators hypothesize that whole grain consumption over a period of 6 weeks will alter the gut microflora toward a more beneficial bacterial profile, improve the immune response while reducing oxidative stress and inflammatory markers, have favorable effects on factors influencing the regulation of body weight and composition,increase bacterial vitamin K synthesis, and beneficially effect surrogate markers of cholesterol synthesis/absorption, vitamin D concentrations, and whole genome DNA methylation patterns. In statin users it is hypothesized that, consumption of whole grains will alter statin pharmacokinetics by decreasing rate of statin absorption, resulting in more sustained plasma concentrations.

Detailed Description

This study is a randomized parallel-arm trial using a six-week dietary intervention following a 2 week run-in period. Healthy volunteers will be randomized to two groups (n=40/group), and consume either a diet rich in whole grains or a diet rich in refined grains provided at estimated energy requirements for 6 weeks. Outcomes will be measured during the run-in period and at week 6 of the intervention. To control for variation in microbiota an additional 10 volunteers will serve as "negative controls" and not undergo any diet intervention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
108
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Whole grain rich dietWhole grainsParticipants in the whole grain (WG) group will receive a diet providing 100% of energy requirements in a diet rich in whole grains.
Refined grain rich dietRefined grainsParticipants in the refined grain (RG) group will receive a diet providing 100% of energy requirements in a diet rich in refined grains.
Primary Outcome Measures
NameTimeMethod
change in Lymphocyte proliferationweek 2 of washout diet and week 6 of diet intervention

Whole blood collected at baseline (week 2 of washout period) and at week-6 of the diet intervention will be investigated for the ability of lymphocytes to proliferate by quantifying the incorporation of tritium following mitogen stimulation.

change in T Cell-mediated immunityweek 2 of washout diet and week 6 of diet intervention

Delayed-type hypersensitivity (DTH) and lymphocyte proliferation will be measured at baseline (week 2 of washout period) and at week-6 of the diet intervention to assess adaptive immune function, specifically T cell-mediated immunity.

change in Natural Killer Functionweek 2 of washout diet and week 6 of diet intervention

The ability of peripheral blood mononuclear cells to bind and kill leukemia cells will be measured at baseline (week 2 of washout period) and at week-6 of the diet intervention

change in Salivary immunoglobulin A (IgA)week 2 of washout diet and week 6 of intervention diet

Salivary IgA will be analyzed at baseline (week 2 of washout period) and at week-6 of the diet intervention.

change in Cytokinesweek 2 of washout diet and week 6 of diet intervention

Peripheral blood and stool samples will be analyzed at baseline (week 2 of washout diet) and week-6 of diet intervention for cytokines.

Secondary Outcome Measures
NameTimeMethod
change in vitamin K statusweek 2 of washout diet and week 6 of intervention diet

Fecal menaquinones concentrations; Fasting serum phylloquinone and menaquinones concentration from 72-hour stool collected at baseline (week 2 of washout diet) and at week 6 of intervention diet

change in body compositionweek 2 of washout diet and week 6 of intervention diet

Fat and fat free mass; waist and hip circumference

change in appetiteWeekly for 8 weeks

Visual analog scales to assess hunger, fullness and satisfaction while on the study diet

change in glycemic regulationweek 2 of washout diet and week 6 of intervention diet

48 hr continuous glucose monitoring; fasting serum glucose; fasting serum insulin; HOMA-IR

change in quality of lifeweek 2 of washout diet and week 6 of intervention diet

Questionnaires will be administered at baseline (week 2 of washout diet) and week 6 of intervention diet

change in total stool anaerobic and aerobic bacterial countsweek 2 of washout diet and week 6 of intervention diet

Will be measured from 72-hour stool sample collected at baseline (week 2 of washout diet) and week 6 of intervention diet

change in stool energy contentweek 2 of washout diet and week 6 of intervention diet

Will be measured from 72-hour stool sample collected at baseline (week 2 of washout diet) and week 6 of intervention diet

change in cardiovascular health risk factorsweek 2 of washout diet and week 6 of intervention diet

Consumption of the whole grain (WG) diet will be beneficial for multiple outcomes of cardiovascular health including a favorable blood lipid profile (low density lipoprotein, very low-density lipoprotein, high density lipoprotein, total cholesterol and triglycerides), and a decrease in blood pressure, and in oxidative stress status (secondary hypothesis).

change in resting energy metabolismweek 2 of washout diet and week 6 of intervention diet

Resting energy expenditure; substrate oxidation at rest

change in breath hydrogen and methaneweek 2 of washout diet and week 6 of intervention diet
change in stool pHweek 2 of washout diet and week 6 of intervention diet

Will be measured from 72-hour stool sample collected at baseline (week 2 of washout diet) and week 6 of intervention diet

change in 72hr fecal weightweek 2 of washout diet and week 6 of intervention diet

Will be measured from 72-hour stool sample collected at baseline (week 2 of washout diet) and week 6 of intervention diet

change in stool water contentweek 2 of washout diet and week 6 of intervention diet

Will be measured from 72-hour stool sample collected at baseline (week 2 of washout diet) and week 6 of intervention diet

change in DNA methylationweek 2 of washout diet and week 6 of intervention diet
change in gut microbiota compositionweek 2 of washout diet and week 6 of intervention diet

Phylogenetic composition and relative abundance of bacteria in stool will be analyzed from 24-hour fresh sample collected at baseline (week 2 of washout diet) and at week 6 of intervention diet

change in fasting gut hormone concentrationweek 2 of washout diet and week 6 of intervention diet

Plasma glucagon-like peptide-1 and peptide-YY will be measured from blood samples collected at baseline (week 2 of washout diet) and week 6 of intervention diet

change in fasting serum leptinweek 2 of washout diet and week 6 of intervention diet
change in eating behaviorsweek 2 of washout diet and week 6 of intervention diet

Questionnaires will be administered at baseline (week 2 of washout diet) and week 6 of intervention diet

change in concentrations of the cholesterol synthesis (squalene, desmosterol, lathosterol) and absorption (campesterol, sitosterol, cholestanol) markersweek 2 of washout diet and week 6 of intervention diet

Plasma squalene, desmosterol, lathosterol), campesterol, sitosterol, and cholestanol concentrations will be measured at baseline (week 2 of washout diet) and week 6 of intervention diet

change in serum vitamin Dweek 2 of washout diet and week 6 of intervention diet

Trial Locations

Locations (1)

HNCRA at Tufts University

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath